Published in J Hypertens on April 01, 2007
Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J (2008) 2.31
Properties and therapeutic potential of transient receptor potential channels with putative roles in adversity: focus on TRPC5, TRPM2 and TRPA1. Curr Drug Targets (2011) 1.06
Contribution and regulation of TRPC channels in store-operated Ca2+ entry. Curr Top Membr (2013) 1.03
TRPC channel lipid specificity and mechanisms of lipid regulation. Cell Calcium (2009) 1.03
TRP channels and their implications in metabolic diseases. Pflugers Arch (2010) 1.00
On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease. Cardiovasc Hematol Agents Med Chem (2012) 0.91
Macrophage function in atherosclerosis: potential roles of TRP channels. Channels (Austin) (2012) 0.89
Integration of transient receptor potential canonical channels with lipids. Acta Physiol (Oxf) (2011) 0.86
TRPC3 activation by erythropoietin is modulated by TRPC6. J Biol Chem (2008) 0.85
Mitochondrial respiratory dysfunctions of blood mononuclear cells link with cardiac disturbance in patients with early-stage heart failure. Sci Rep (2015) 0.75
Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet (2011) 4.70
The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke (2003) 4.63
Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int (2003) 3.54
A unified nomenclature for the superfamily of TRP cation channels. Mol Cell (2002) 2.99
Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension (2012) 2.95
Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res (2007) 2.47
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest (2004) 2.36
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci U S A (2006) 2.16
Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab (2010) 2.11
Impact of atrial fibrillation on the accuracy of oscillometric blood pressure monitoring. Hypertension (2013) 2.10
Homo- and heteromeric assembly of TRPV channel subunits. J Cell Sci (2005) 1.93
Arterial response to shear stress critically depends on endothelial TRPV4 expression. PLoS One (2007) 1.79
Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit (2012) 1.74
Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*. J Hypertens (2006) 1.74
Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br J Pharmacol (2005) 1.72
Molecular and functional characterization of the melastatin-related cation channel TRPM3. J Biol Chem (2003) 1.69
Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am J Physiol Cell Physiol (2003) 1.69
Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring) (2007) 1.67
Effect of the venous catheter site on transpulmonary thermodilution measurement variables. Crit Care Med (2007) 1.63
Adenosine 5'-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor. Circ Res (2008) 1.61
Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis. Hypertension (2005) 1.52
Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected]. Mol Pharmacol (2004) 1.49
Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus. Biochem Biophys Res Commun (2004) 1.47
Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure. Circulation (2004) 1.46
Small artery elasticity assessed by pulse wave analysis is no measure of endothelial dysfunction. J Hypertens (2007) 1.46
Angiotensinogen promoter haplotypes are associated with blood pressure in untreated hypertensives. J Hypertens (2004) 1.45
High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome. Metabolism (2007) 1.45
Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique. Artif Organs (2013) 1.42
The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation (2003) 1.41
G protein-coupled receptor-mediated activation of p110β by Gβγ is required for cellular transformation and invasiveness. Sci Signal (2012) 1.38
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens (2007) 1.36
Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels. FASEB J (2007) 1.31
Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer (2004) 1.29
The mammalian melastatin-related transient receptor potential cation channels: an overview. Pflugers Arch (2005) 1.28
Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction. Circ Res (2010) 1.28
Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients. Nephrol Dial Transplant (2008) 1.23
Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med (2005) 1.19
Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood (2003) 1.19
Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit (2010) 1.19
Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3. Br J Pharmacol (2011) 1.18
Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol (2011) 1.17
Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid. Br J Pharmacol (2006) 1.16
Low-grade albuminuria and cardiovascular risk : what is the evidence? Clin Res Cardiol (2007) 1.16
Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes (2008) 1.16
Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats. Hypertension (2008) 1.16
Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res (2005) 1.14
Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant (2012) 1.13
Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma. Proc Natl Acad Sci U S A (2009) 1.13
High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. Cardiovasc Res (2012) 1.11
Transient receptor potential melastatin 2 is required for lipopolysaccharide-induced cytokine production in human monocytes. J Immunol (2010) 1.11
TRPV4-mediated regulation of epithelial permeability. FASEB J (2006) 1.10
Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol (2006) 1.10
Transient receptor potential canonical type 3 channels--their evolving role in hypertension and its related complications. J Cardiovasc Pharmacol (2013) 1.10
Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase. Hypertension (2004) 1.08
Noninvasive evaluation of renal allograft fibrosis by transient elastography--a pilot study. Transpl Int (2010) 1.08
Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs). Proc Natl Acad Sci U S A (2013) 1.06
Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta. Biochem Biophys Res Commun (2007) 1.06
Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem (2008) 1.06
High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes. Diabetes (2010) 1.01
Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways. Hypertension (2010) 1.00
Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens (2008) 1.00
Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury. Clin J Am Soc Nephrol (2011) 0.99
A physiogenomic approach to study the regulation of blood pressure. Physiol Genomics (2005) 0.97
Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol (2010) 0.97
Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation. Hum Mol Genet (2003) 0.97
TRPM3 is expressed in sphingosine-responsive myelinating oligodendrocytes. J Neurochem (2010) 0.96
Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovasc Res (2011) 0.95
Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis (2008) 0.94
Characterization of polymer membranes by MALDI mass-spectrometric imaging techniques. Anal Chem (2013) 0.94
Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca(2+) -permeable TRPC6 channels. Hippocampus (2012) 0.93
Transient receptor potential channels in essential hypertension. J Hypertens (2006) 0.93
Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels. J Cell Mol Med (2010) 0.92
The role of transient receptor potential channels in metabolic syndrome. Hypertens Res (2008) 0.92
Too old to benefit from sports? The cardiovascular effects of exercise training in elderly subjects treated for isolated systolic hypertension. Kidney Blood Press Res (2007) 0.92
Increased TRPC3 expression in vascular endothelium of patients with malignant hypertension. Mod Pathol (2009) 0.91
Increased transient receptor potential channel TRPC3 expression in spontaneously hypertensive rats. Am J Hypertens (2005) 0.91
The p101 subunit of PI3Kγ restores activation by Gβ mutants deficient in stimulating p110γ. Biochem J (2012) 0.91